Answer
The UK licence requires an activating ESR1 mutation, so a validated plasma test is used to identify patients whose cancer meets this criterion.
Sources for this answer
- Korserdu (elacestrant) 86mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.